TITLE:
Vaccine Therapy for Patients With Stage III Melanoma

CONDITION:
Malignant Melanoma

INTERVENTION:
CancerVax vaccine (CANVAXIN)

SUMMARY:

      This is a Phase 3 study in patients with melanoma that has spread to the lymph nodes (stage
      III), and who have had all of their cancer surgically removed. The purpose of this study is
      to evaluate the ability of the CancerVax vaccine to prevent or slow the recurrence of
      melanoma.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 80 Years
Criteria:

        -  Must have Stage III melanoma

          -  Must have had all clinically-detectable disease surgically removed

          -  Cannot be taking any medications, or undergoing any therapies which compromise the
             functioning of your immune system (ie. Some corticosteroids, and certain types of
             radiation therapy)

          -  Cannot have HIV or Hepatitis A, B, or C
      
